Drugs that contain Viltolarsen

1. Drug name - VILTEPSO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10870676 NIPPON SHINYAKU Antisense nucleic acids
Aug, 2031

(8 years from now)

US9079934 NIPPON SHINYAKU Antisense nucleic acids
Aug, 2031

(8 years from now)

CN103154245B NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

CN103154245A NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

IN323500B NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

IN201302817P1 NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

EP3018211A1 NIPPON SHINYAKU Antisense Nucleic Acids
Feb, 2022

(7 months ago)

EP3018211B1 NIPPON SHINYAKU Antisense Nucleic Acids
Feb, 2022

(7 months ago)

EP2612917A1 NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

EP2612917A4 NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

EP2612917B1 NIPPON SHINYAKU Antisense Nucleic Acid
Aug, 2031

(8 years from now)

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
250MG/5ML (50MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.